FDA Inspection 971971 — Apex Biotechnology Corp.
The FDA completed an inspection of Apex Biotechnology Corp. on April 26, 2016 in Xin Zhu Shi. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2016
- Fiscal Year
- 2016
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Xin Zhu Shi (Taiwan)